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The purpose of this work is the study of binding of substances (177Lu-DOTA-
[Lys3]bombesin,  177Lu-NOTA-[Lys3]bombesin, 177Lu-PCTA-[Lys3]bombesin, and 177Lu-
DOTA-MG47) to plasma proteins by equilibrum dialysis in 37°C, particularly using 
plasma samples of beef, rabbit, rat and human. Within this group, these substances were 
compared interspecifically.  
The substances 177Lu-DOTA-[Lys3]bombesin,  177Lu-NOTA-[Lys3]bombesin, 177Lu-
PCTA-[Lys3]bombesin, and 177Lu-DOTA-MG47 are the newly developed receptor-
specific radiolabeled peptides. 
For all the newly collected data, the interspecific comparison and subsequent statistical 
evaluation was performed. The indicated bombesin derivates were compared and 
statistically analyzed even between themselves. 
During the interspecies comparisons and the determination of the statistical significance 
of the data, there were found statistically significant and statistically highly significant 
differences between some of the examined samples. 
 A highly significant difference was found during comparing with samples of 177Lu-NOTA-
[Lys3]bombesin and statistical evaluation, there was found a statistically highly 
significant difference. 
Despite the differences found, it is clear that the plasma binding concerning all the 
examined substances of this work was so insignificant that it will not affect the 
pharmacokinetics. 
 
